Limited survival in patients with carcinomatosis from foregut malignancies after cytoreduction and continuous hyperthermic peritoneal perfusion

Journal of Gastrointestinal Surgery

Volumn 9, Issue 9, 2005, Pages 1346-1353

  Farma, Jeffrey M ^a   Pingpank, James F ^a   Libutti, Steven K ^a   Bartlett, David L ^b   Ohl, Susan ^a   Beresneva, Tatiana ^a   Alexander, H Richard ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Duodenal cancer; Gastric cancer; Pancreatic cancer; Peritoneal carcinomatosis; Peritoneal perfusion; Regional therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ADENOCARCINOMA; ADULT; AGED; CONFERENCE PAPER; DUODENUM TUMOR; EQUIPMENT DESIGN; FEMALE; HUMAN; HYPERTHERMIC THERAPY; INSTRUMENTATION; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PANCREAS TUMOR; REGIONAL PERFUSION; STOMACH TUMOR; SURVIVAL RATE; TUMOR RECURRENCE;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; COMBINED MODALITY THERAPY; DUODENAL NEOPLASMS; EQUIPMENT DESIGN; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 28644451665     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2005.06.016     Document Type: Conference Paper

References (20)

1. P. Pilati, S. Mocellin, and C.R. Rossi Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma Ann Surg Oncol 10 2003 508 513
2. T. Murakami Surgical treatment of gastric cancer H.L. Bockus Bockus Gastroenterology, Vol. 1 3rd ed 1974 WB Saunders Philadelphia 983 997
3. Y. Maehara Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion Am J Surg 168 1994 36 40
4. D.L. Bartlett, J.F. Buell, and S.K. Libutti A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis Cancer 83 1998 1251 1261
5. H.R. Alexander, J.F. Buell, and D.L. Fraker Rationale and clinical status of continuous hyperthermic peritoneal perfusion (CHPP) for the treatment of peritoneal carcinomatosis V. DeVita S. Hellman S. Rosenberg Principles and Practices of Oncology Updates 9th ed 1995 JB Lippincott Philadelphia 1 9
6. M. Markman Intraperitoneal paclitaxel in the management of ovarian cancer Semin Oncol 22 1995 86 87
7. H.R. Alexander, and D.L. Fraker Continuous hyperthermic peritoneal perfusion with cisplatin in the treatment of peritoneal carcinomatosis Regul Cancer Treat 8 1995 2 7
8. B.J. Park, H.R. Alexander, and S.K. Libutti Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP) Ann Surg Oncol 6 1999 582 590
9. S. Fujimoto, R.D. Shgrestha, and M. Kokubun Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding Ann Surg 208 1988 36 41
10. T. Fujimura, Y. Yonemura, and S. Fushida Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation Cancer 65 1990 65 71
11. T. Fujimura, Y. Yonemura, and K. Muraoka Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study World J Surg 18 1994 150 155
12. S. Koga, R. Hamazoe, M. Maeta, N. Shimizu, A. Murakami, and T. Wakatsuki Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C Cancer 61 1988 232 237
13. Y. Yonemura, T. Fujimura, and S. Fushida Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study Hepato-gastroenterology 48 2001 1776 1782
14. C.R. Rossi, P. Pilati, and S. Mocellin Hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from gastric adenocarcinoma Suppl Tumori 2 2003 S54 S57
15. S.B. Howell, C.E. Pfeifle, and W.E. Wung Intraperitoneal cisplatin with sodium thiosulfate protection Ann Intern Med 97 1982 845 851
16. S.B. Howell, C.E. Pfeifle, W.E. Wung, and R.A. Olshen Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection Cancer Res 43 1983 1426 1431
17. A.L. Feldman, S.K. Libutti, and J.F. Pingpank Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy J Clin Oncol 21 2003 4560 4567
18. V.J. Verwaal, S. van Ruth, and E. de Bree Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer J Clin Oncol 21 2003 3737 3743
19. Y. Yonemura, T. Kawamura, E. Bandou, S. Takahashi, T. Sawa, and N. Matsuki Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion Br J Surg 92 2005 370 375
20. O. Glehen, V. Schreiber, and E. Cotte Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer Arch Surg 139 2004 20 26